Literature DB >> 25773214

Antibiotic trials for community-acquired pneumonia.

Matthew P Fox1, Abdullah H Baqui2, Patricia L Hibberd3, Robert E Black2, Mathuram Santosham4, Zulfiqar Bhutta5, Donald M Thea6.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25773214     DOI： 10.1016/S2213-2600(15)00044-2

Source DB:  PubMed          Journal:  Lancet Respir Med        ISSN： 2213-2600            Impact factor:   30.700


× No keyword cloud information.
  2 in total

1.  A double blind community-based randomized trial of amoxicillin versus placebo for fast breathing pneumonia in children aged 2-59 months in Karachi, Pakistan (RETAPP).

Authors:  Fyezah Jehan; Muhammad Imran Nisar; Salima Kerai; Nick Brown; Benazir Balouch; Zulfiqar Hyder; Gwen Ambler; Amy Sarah Ginsburg; Anita K M Zaidi
Journal:  BMC Infect Dis       Date:  2016-01-13       Impact factor: 3.090

Review 2.  Short-course versus long-course intravenous therapy with the same antibiotic for severe community-acquired pneumonia in children aged two months to 59 months.

Authors:  Zohra S Lassi; Aamer Imdad; Zulfiqar A Bhutta
Journal:  Cochrane Database Syst Rev       Date:  2017-10-11
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.